CORE LABORATORIES INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Next earnings (estimated): Wed, April 1, 2026 — 29 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $138M | ↑+7.0% | $5M | ↓-33.2% | 11.5% |
| 2025-09-30 | $135M | ↑+0.1% | $14M | ↑+21.2% | 15.6% |
| 2025-06-30 | $130M | ↓-0.3% | $11M | ↑+17.8% | 11.7% |
| 2025-03-31 | $124M | ↓-4.7% | $-154K | ↓-104.8% | 3.6% |
| 2024-12-31 | $129M | ↑+0.8% | $7M | ↑+236.7% | 11.0% |
| 2024-09-30 | $134M | ↑+7.2% | $12M | ↑+26.9% | 14.7% |
| 2024-06-30 | $131M | ↑+2.1% | $9M | ↓-60.5% | 12.3% |
| 2024-03-31 | $130M | ↑+1.0% | $3M | ↑+35.7% | 6.6% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Revenue
$138M
↑+7.0% +$9M YoY
Net Income
$5M
↓-33.2% -$2M YoY
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Go deeper
CLB Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyCLB Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics